Taysha Gene Therapies grants new hires 384,000 RSUs, options for 92,400 shares under inducement plan
TSHA•Taysha Gene Therapies granted four new employees 384,000 restricted stock units and options covering 92,400 shares under its 2023 Inducement Plan. The options have a $4.74 exercise price and a 10-year term.
1. Awards to new hires
The RSUs vest in four equal annual installments beginning on the first anniversary of the vesting commencement date. The options vest over four years, with 25% vesting after one year and the remainder vesting monthly over the following 36 months.
